Napredna pretraga

Pregled bibliografske jedinice broj: 49406

Effectiveness of imidazole and quinuclidine derivatives on acetyl cholinesterase inhibited by soman in vitro and in vivo


Lucić, Ana; Radić, Božica; Primožič, Ines; Binenfeld, Zlatko
Effectiveness of imidazole and quinuclidine derivatives on acetyl cholinesterase inhibited by soman in vitro and in vivo // Technical Program of CB Medical Treatment Symposium: The Second Chemical and Biological Medical Treatment Symposium / Price, Richard (ur.).
Spiez: ASA, 1996. (poster, međunarodna recenzija, sažetak, znanstveni)


Naslov
Effectiveness of imidazole and quinuclidine derivatives on acetyl cholinesterase inhibited by soman in vitro and in vivo

Autori
Lucić, Ana ; Radić, Božica ; Primožič, Ines ; Binenfeld, Zlatko

Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni

Izvornik
Technical Program of CB Medical Treatment Symposium: The Second Chemical and Biological Medical Treatment Symposium / Price, Richard - Spiez : ASA, 1996

Skup
CB Medical Treatment Symposium, The Second Chemical and Biological Medical Treatment Symposium

Mjesto i datum
Spiez, Švicarska, 7-12.07.1996

Vrsta sudjelovanja
Poster

Vrsta recenzije
Međunarodna recenzija

Ključne riječi
Soman; quinuclidinium oximes; AcHE

Sažetak
In this paper, new synthesized oxime derivatives of imidazoles and quinuclidines were tested in vitro using human erythrocyte AChE inhibited by soman and in vivo using soman poisoned mice. The inhibitory power (IC50, concentration of the tes compounds, oximes, that inhibit to 50 % of the AChE activity), acute toxicity (LD50), as well as reactivating and protective capacities, with respect to soman-inhibited AChE were tested for each of the synthesized oximes. Antidotal characteristics of the new synthesized oximes were compared and related to their chemical structures. Derivatives of imidazoles demonstrated mostly weak reactivatin and protective characteristics, both for the in vitro and in vivo cases. These characteristics were indempendent of the substituents on N phenyl imidazolium oximes. Of the imidazoles, only BMR-3 oxime strongly reactivated the soman-inhibited AChE (55%), i.e., in vitro, for human erythrocutes. BMR-4 oxime, in combination with atropine sulfate, provided effective protection in vivo (for mice)against 1.8 and 2.2 LD 50 of soman. Ont he contrary, all tested quinuclidine oximes showed very good protection in vivo (for example, BM-1 protects agains 4 LD 50 of soman), but were ineffective in vitro, i.e., against soman-inhibited human erythrocyte AChE. The results indicate that in vivo effectiveness of quinuclidine oximes against soman poisoning is not related to their reactivating or protective potentials for AChE measured in in vitro experiments; their good protective effect is more likely to be related to other mechanisms of the cholinergic system.

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti



POVEZANOST RADA


Projekt / tema
00220105

Ustanove
Institut za medicinska istraživanja i medicinu rada, Zagreb